InvestorsHub Logo
Replies to #51472 on Biotech Values
icon url

xrymd

08/24/07 2:11 PM

#51473 RE: DewDiligence #51472

Dew: The physicians I have spoke to (about 10) who use Artefill say it is really easy to use. They were initially leary of it because of the permanence but when they tried it they and the patients were pleased. Because it is so pliable it is hard to really screw it up. That said there is alot of competition in the dermal filler space. The next few quarters will tell if there is any traction in the sales growth. The docs stated the obvious, the more you use a product the more you get comfortable with it. The thought of permanence of a procedure has likely hurt sales and the high cost of Artefill compared to Botox also likely hasn't helped. I am actually nibbling on a few more shares at $4.50.